128 related articles for article (PubMed ID: 38042266)
1. Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis.
Yong JH; Mai AS; Matetić A; Elbadawi A; Elgendy IY; Lopez-Fernandez T; Mamas MA
Am J Cardiol; 2024 Feb; 212():80-102. PubMed ID: 38042266
[TBL] [Abstract][Full Text] [Related]
2. Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
van Veldhuisen SL; Gorter TM; van Woerden G; de Boer RA; Rienstra M; Hazebroek EJ; van Veldhuisen DJ
Eur Heart J; 2022 May; 43(20):1955-1969. PubMed ID: 35243488
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis.
Galimzhanov A; Istanbuly S; Tun HN; Ozbay B; Alasnag M; Ky B; Lyon AR; Kayikcioglu M; Tenekecioglu E; Panagioti M; Kontopantelis E; Abdel-Qadir H; Mamas MA
Eur J Prev Cardiol; 2023 Dec; 30(18):2018-2031. PubMed ID: 37499186
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
[TBL] [Abstract][Full Text] [Related]
5. Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database.
Hui SK; Sharma A; Docherty K; McMurray JJV; Pitt B; Dickstein K; Pfeffer MA; Girerd N; Rossignol P; Ferreira JP; Zannad F
Eur Heart J Acute Cardiovasc Care; 2021 Apr; 10(2):127-131. PubMed ID: 33620418
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy.
Pan Y; Davis PB; Kaebler DC; Blankfield RP; Xu R
Cardiovasc Diabetol; 2022 Sep; 21(1):170. PubMed ID: 36050764
[TBL] [Abstract][Full Text] [Related]
7. Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.
Salah HM; Al'Aref SJ; Khan MS; Al-Hawwas M; Vallurupalli S; Mehta JL; Mounsey JP; Greene SJ; McGuire DK; Lopes RD; Fudim M
Am Heart J; 2021 Feb; 232():10-22. PubMed ID: 33214130
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis.
Jaiswal V; Ang SP; Yaqoob S; Ishak A; Chia JE; Nasir YM; Anjum Z; Alraies MC; Jaiswal A; Biswas M
Eur J Prev Cardiol; 2022 Oct; 29(14):1881-1892. PubMed ID: 35857821
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics for secondary prevention of coronary heart disease.
Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.
Kanie T; Mizuno A; Takaoka Y; Suzuki T; Yoneoka D; Nishikawa Y; Tam WWS; Morze J; Rynkiewicz A; Xin Y; Wu O; Providencia R; Kwong JS
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013650. PubMed ID: 34693515
[TBL] [Abstract][Full Text] [Related]
11. Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis.
Müllerová H; Marshall J; de Nigris E; Varghese P; Pooley N; Embleton N; Nordon C; Marjenberg Z
Ther Adv Respir Dis; 2022; 16():17534666221113647. PubMed ID: 35894441
[TBL] [Abstract][Full Text] [Related]
12. Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome.
Micheli S; Agnelli G; Caso V; Alberti A; Palmerini F; Venti M; Paciaroni M
J Neurol; 2012 Jan; 259(1):106-10. PubMed ID: 21691731
[TBL] [Abstract][Full Text] [Related]
13. ASSOCIATION OF RETINAL VEIN OCCLUSION WITH CARDIOVASCULAR EVENTS AND MORTALITY: A Systematic Review and Meta-analysis.
Wu CY; Riangwiwat T; Limpruttidham N; Rattanawong P; Rosen RB; Deobhakta A
Retina; 2019 Sep; 39(9):1635-1645. PubMed ID: 30829987
[TBL] [Abstract][Full Text] [Related]
14. Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: A Meta-Analysis of Randomized Clinical Trials.
Kumar K; Kheiri B; Simpson TF; Osman M; Rahmouni H
Am J Med; 2020 Nov; 133(11):e625-e630. PubMed ID: 32389659
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis.
Diallo A; Carlos-Bolumbu M; Galtier F
Acta Diabetol; 2023 Dec; 60(12):1651-1662. PubMed ID: 37439858
[TBL] [Abstract][Full Text] [Related]
16. Smoking cessation for secondary prevention of cardiovascular disease.
Wu AD; Lindson N; Hartmann-Boyce J; Wahedi A; Hajizadeh A; Theodoulou A; Thomas ET; Lee C; Aveyard P
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014936. PubMed ID: 35938889
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients.
Ducluzeau PH; Fauchier G; Herbert J; Semaan C; Halimi JM; Angoulvant D; Fauchier L
Diabetes Metab; 2023 May; 49(3):101429. PubMed ID: 36736892
[TBL] [Abstract][Full Text] [Related]
18. Cumulative incidence and mortality rate of cardiovascular complications due to laboratory-confirmed influenza virus infection: A systematic review and meta-analysis.
Ouranos K; Vassilopoulos S; Vassilopoulos A; Shehadeh F; Mylonakis E
Rev Med Virol; 2024 Jan; 34(1):e2497. PubMed ID: 38126946
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose-response meta-analysis involving 10 randomized clinical trials and 71 553 individuals.
Lin DS; Yu AL; Lo HY; Lien CW; Lee JK; Chiang FT; Tu YK
Eur J Endocrinol; 2023 Jul; 189(1):S17-S25. PubMed ID: 37474112
[TBL] [Abstract][Full Text] [Related]
20. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
